Members of our CSI Scientific Advisory Board are recognized experts in their specialty areas, which include differential diagnosis of depression, dementia, and other psychiatric disorders, as well as degenerative neurologic diseases.

David Grodberg, M.D.
Dr. Grodberg received his M.D. from the Albert Einstein College of Medicine, where he completed an internship and residency in psychiatry. He also completed a two-year fellowship in child and adolescent psychiatry at the Yale Child Study Center, where he focused on ADHD and co-authored a chapter on language delays in Child and Adolescent Psychiatric Clinics of North America. He maintains a private practice in New York City and serves on the faculty at Mount Sinai School of Medicine.

Alice Medalia, Ph.D.
Dr. Medalia is an associate professor of clinical neurology, psychiatry, and behavioral sciences at the Albert Einstein College of Medicine and the director of neuropsychology for the Department of Psychiatry and Behavioral Sciences at Montefiore Medical Center in New York City. The author of more than 50 publications, she has consulted worldwide to agencies interested in providing cognitive remediation services to behavioral health/mentally ill populations. She has participated in the editorial review process of a dozen professional journals and served as a consultant to numerous research grants. Dr. Medalia frequently lectures on her research on evidence-based treatment and treatment outcomes of cognitive impairment in psychiatric populations.

L. Stephen Miller, Ph.D.
Dr. Miller is an associate professor of clinical psychology in the University of Georgia's Psychology Department. He is also Director of UGA's Memory Assessment Clinic, co-director of the UGA Human Neuroimaging Facility, and a faculty member of the UGA Gerontology Center. Dr. Miller's research interests center on the relationship between pathological changes of the brain and their influence on behavior. Specialty areas include dementia and schizophrenia. Dr. Miller has published more than 30 research articles and book chapters and has presented his work at numerous scientific conferences. His research has been funded by the National Institute of Aging, the U.S. Department of Agriculture, the Center for Applied Cognitive Research on Aging, and the Agency for Health Care Policy Research, among others.

Bruce Phariss, M.D.
Dr. Phariss is a Diplomate of the American Board of Psychiatry and Neurology and holds subspecialty certification in addiction psychiatry. He is clinical instructor of psychiatry and public health at the Weill Medical College of Cornell University and serves as medical director for two state-licensed intensive outpatient substance abuse treatment facilities: The Midtown Center for Treatment and Research, Weill Medical College of Cornell University, and Exponents Treatment Exchange. Dr. Phariss maintains a private psychiatric practice in New York City. He teaches medical students and residents and has lectured extensively to professional groups about addiction.

John A. Toner, Ed.D., M.Phil.
Dr. Toner is an associate clinical professor of medical psychology in psychiatry at the Stroud Center of the Columbia University Faculty of Medicine and senior research scientist at the New York State Psychiatric Institute. His current research, which is supported by the Calderone Prize for Faculty Research at Columbia, focuses on chronically mentally ill patients and geriatric depression in dementia. The author of two recent books on long-term care of the frail elderly, Dr. Toner has published more than 50 scientific articles in the fields of geriatrics and gerontology and serves on the editorial and advisory boards of several journals, including the Journal of Interprofessional Care, an international journal based in London.

David M. Erlanger, Ph.D.
Dr. Erlanger received his doctorate in psychology from Columbia University and completed training in clinical neuropsychology at the Albert Einstein College of Medicine and the Weill Medical College of Cornell University. He is on the faculties of the Albert Einstein College of Medicine/Montefiore Hospital and Columbia University/Teachers College and serves as a consultant in research methods and assessment to the New York State Psychiatric Institute of Columbia-Presbyterian Medical Center.

Daniel J. Feldman, Ph.D.
Dr. Feldman completed training in neuropsychology at the Weill Medical College of Cornell University. Clinically, he has worked primarily doing neuropsychological assessment of adults in outpatient and medical-legal settings. He has published and continues to study in the areas of neuropsychology, personality research, psychometrics, and advanced statistical techniques for the behavioral sciences. At present, he leads pharmaceutical market research in oncology.